Ani Pharmaceuticals, Inc. · NASDAQ:ANIP
Lalwani Nikhil sold 5,400 Ani Pharmaceuticals, Inc. shares (Form 4)
Traded Oct 15, 2026 · Filed Oct 16, 2026
On Oct 15, 2026, Lalwani Nikhil (Director, PRESIDENT & CEO) sold 5,400 Ani Pharmaceuticals, Inc. shares at US$71.89 for US$388K under a trading plan, leaving 333,689 shares. Filed Oct 16, 2026 (Form 4).
- Sold
- 5,400 shares
- Price
- US$71.89
- Value
- US$388K
- Holding after
- 333,689 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, PRESIDENT & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Common Stock | Sale | 5,400 | US$71.89 | 333,689 | Direct |
Source
Download original · View original at SEC
Related
- Ani Pharmaceuticals, Inc.
- Lalwani Nikhil
- Ani Pharmaceuticals, Inc. shareholders
- Form 4 · Lalwani Nikhil · Sep 16, 2026
- Form 4 · Lalwani Nikhil · Aug 26, 2026
- Form 4 · Lalwani Nikhil · May 13, 2026
- Form 4 · Cook Meredith · Oct 13, 2026
- Form 4 · Carey Stephen P. · Sep 30, 2026
- Form 4 · Cook Meredith · Sep 14, 2026
- Form 4 · Thoma Jeanne · Sep 14, 2026
- Form 4 · Carey Stephen P. · Sep 1, 2026